Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

PAR FORM

  • FDA Approval
  • May 03, 2023, 11:38 UTC
  • 28
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

MYLAN PHARMS

  • FDA Approval
  • May 03, 2023, 11:38 UTC
  • 27
  • 0 comments

FDA approve CABERGOLINE

Comment Full text

CELLTRION

  • FDA Approval
  • May 03, 2023, 11:38 UTC
  • 27
  • 0 comments

FDA approve TELMISARTAN

Comment Full text

SUN PHARM INDS INC

  • FDA Approval
  • May 03, 2023, 11:38 UTC
  • 23
  • 0 comments

FDA approve CLONAZEPAM

Comment Full text

PAR PHARM

  • FDA Approval
  • May 03, 2023, 11:38 UTC
  • 28
  • 0 comments

FDA approve FLUOXETINE HYDROCHLORIDE; OLANZAPINE

Comment Full text

AVADEL CNS PHARMA LLC

  • FDA Approval
  • May 02, 2023, 11:36 UTC
  • 29
  • 0 comments

FDA approve SODIUM OXYBATE

Comment Full text

GILEAD SCIENCES INC

  • FDA Approval
  • May 02, 2023, 11:36 UTC
  • 29
  • 0 comments

FDA approve BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Comment Full text

OTSUKA PHARM CO LTD

  • FDA Approval
  • April 28, 2023, 17:40 UTC
  • 33
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text

ALEMBIC PHARMS LTD

  • FDA Approval
  • April 28, 2023, 17:23 UTC
  • 30
  • 0 comments

FDA approve DOXYCYCLINE

Comment Full text

TEVA PHARMS USA INC

  • FDA Approval
  • April 28, 2023, 17:17 UTC
  • 30
  • 0 comments

FDA approve THALIDOMIDE

Comment Full text
  • Previous
  • 827
  • 828
  • 829
  • 830
  • 831
  • Next

Search

News categories

  • Technical Exchange News(12129)
  • Event(5665)
  • SEC News(254959)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152015)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin